XBiotech Inc. — Director's Dealing 2019

Feb 14, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: XBiotech Inc. (XBIT)
CIK: 0001626878
Period of Report: 2018-12-21

Reporting Person: RENNES FONDATION (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-12-21	Common Stock	P	4200	$6.24	Acquired	3590182	Direct
2018-12-27	Common Stock	P	2200	$4.98	Acquired	3592382	Direct
2019-01-02	Common Stock	P	900	$5.15	Acquired	3593282	Direct
2019-02-06	Common Stock	P	35000	$8.93	Acquired	3628282	Direct
2019-02-06	Common Stock	P	30000	$9.49	Acquired	3658282	Direct
2019-02-07	Common Stock	P	40000	$10.00	Acquired	3698282	Direct